IRF-1-mediated IFN-γ enhancement of TRAIL-induced apoptosis |
Park, Sang-Youel
(Bio-Safty Research Institute, Chonbuk National University)
Seol, Jae-Won (College of Veterinary Medicine, Chonbuk National University) Lee, You-Jin (College of Veterinary Medicine, Chonbuk National University) Kang, Seog-Jin (National Livestock Research Institute) Kim, In-shik (Bio-Safty Research Institute, Chonbuk National University) Kang, Hyung-sub (Bio-Safty Research Institute, Chonbuk National University) Chae, Joon-seok (Bio-Safty Research Institute, Chonbuk National University) Cho, Jong-Hoo (Bio-Safty Research Institute, Chonbuk National University) |
1 | Harada, H., Kitagawa, M., Tanaka, N., Yamamoto, H., Harada, K., Ishihara, M. and Taniguchi, T. Antioncogenic and oncogenic potentials of interferonregulatory factors-1 and -2. Science. 1993, 259, 971-974 |
2 | Kakimi, K., Guidotti, L. G., Koezuka, Y. and Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 2000, 192, 921-930 |
3 | Kim, K. B., Choi, Y. H., Kim, I. K., Chung, C. W., Kim, B. J., Park, Y. M. and Jung, Y. K. Potentiation of Fas- and TRAIL-mediated apoptosis by IFN-gammain A549 lung epithelial cells: enhancement of caspase-8 expression through IFN-response element. Cytokine. 2002, 20, 283-288 |
4 | Sasagawa, T., Hlaing, M. and Akaike, T. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochem.Biophys. Res. Commun. 2000, 272, 674-680 |
5 | Seol, D. W., Li, J., Seol, M. H., Park, S. Y., Talanian, R. V. and Billiar, T. R. Signaling events triggered by tumor necrosis factor-related apoptosis- inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis. Cancer Res. 2001, 61, 1138-1143 |
6 | Tanaka, N., Ishihara, M., Lamphier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino,T., Oren, M. and Taniguchi, T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 1996, 382, 816-818 |
7 | Zhou, Y., Wang, S., Gobl, A. and Oberg, K. The interferon-alpha regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implicationsin carcinoid tumors. Ann. Oncol. 2000, 11, 707-714 |
8 | Seol, D. W. and Billiar, T. R. Cysteine 230 modulates tumor necrosis factor-related apoptosis-inducing ligand activity. Cancer Res. 2000, 60, 3152-3154 |
9 | Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A. and Ashkenazi, A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 1996, 271, 12687-12690 |
10 | Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y. and Taniguchi, T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencingproperties to human IFN-beta gene regulatory elements. EMBO J. 1988, 7, 3397-3405 |
11 | Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C. and Smith, C. A. Identificationand characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995, 3, 673-682 |
12 | Nunokawa, Y. and Tanaka, S. Interferon-gamma inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem. Biophys.Res. Commun. 1992, 188, 409-415 |
13 | Tanaka, N., Ishihara, M. and Taniguchi, T. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Cancer Lett. 1994, 83, 191-196 |
14 | Shin, E. C., Shin, W. C., Choi, Y., Kim, H., Park, J. H. and Kim, S. J. Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)- mediated celldeath in human hepatoma cells. Cancer Immunol Immunother. 2001, 50, 23-30 |
15 | Cha, S. S., Kim, M. S., Choi, Y. H., Sung, B. J., Shin, N. K., Shin, H. C., Sung, Y. C. and Oh, B. H. 2.8 A resolution crystal structure of human TRAIL, acytokine with selective antitumor activity. Immunity. 1999, 11, 253-261 |
16 | Park, S. Y., Billiar, T. R. and Seol, D. W. IFN-g Inhibition of TRAIL-Induced IAP-2 Upregulation, a Possible Mechanism of IFN-g-Enhanced TRAILInducedApoptosis. Biochem. Biophys. Res. Commun. 2002, 291, 233-236 |
17 | Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W. and Taniguchi, T. Cellularcommitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994, 77, 829-839 |
18 | Kirkwood, J. M., Ernstoff, M. S., Trautman, T., Hebert, G., Nishida, Y., Davis, C. A., Balzer, J., Reich, S., Schindler, J. and Rudnick, S. A. In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma. J. Clin. Oncol. 1990, 8, 1070-1082 |
19 | Suk, K., Kim, S., Kim, Y. H., Kim, K. A., Chang, I., Yagita, H., Shong, M. and Lee, M. S. IFN-gamma/TNF-alpha synergism as the final effector inautoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J. Immunol. 2001, 166, 4481-4489 |
20 | Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A. and de Vos, A. M. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell. 1999, 4, 563-571 |
21 | Kirkwood, J. M. and Ernstoff, M. S. Role of interferons in the therapy of melanoma. J. Invest. Dermatol. 1990, 95, 180S-184S |
22 | Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian,E. L. and Taniguchi, T. Induction of endogenous IFNalpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature. 1989, 337, 270-272 |
23 | Nagata, S. Apoptosis by death factor. Cell. 1997, 88, 355-365 |
24 | Park, S. Y., Billiar, T. R. and Seol, D. W. Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor- Related Apoptosis-Inducing Ligand (TRAIL).Biochem. Biophys. Res. Commun. 2002, 291, 150-153 |
25 | Yang, X., Merchant, M. S., Romero, M. E., Tsokos, M., Wexler, L. H., Kontny, U., Mackall, C. L. and Thiele, C. J. Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membraneTR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res. 2003, 63, 1122-1129 |
26 | Fish, S. M., Proujansky, R. and Reenstra, W. W. Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. Gut. 1999, 45, 191-198 |
27 | Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S. and Taniguchi, T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogenactivated T lymphocytes. Nature. 1995, 376, 596-599 |
28 | Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y. and Phipps, M. L. onstruction of adenovirus vectors through Cre-lox recombination. J. Virol. 1997, 71, 1842-1849 |
29 | Park, S. Y. and Seol, D. W. Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis. BiochemBiophys. Res. Commun. 2002, 295, 515-518 |
30 | Taniguchi, T., Lamphier, M. S. and Tanaka, N. IRF- 1: the transcription factor linking the interferon response and oncogenesis. Biochim. Biophys. Acta. 1997, 1333, M9-17 |
31 | Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S. and Taniguchi, T. DNA damage-inducedapoptosis and Ice gene induction in mitogenically activated T lymphocytes require IRF-1. Leukemia. 1997, 11 Suppl 3, 439-440 |
32 | Orange, J. S., Wolf, S. F. and Biron, C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 1994, 152, 1253-1264 |